Grok 4.6 has come out on top in biosecurity testing on LatchBio's benchmarks, beating rival models in monitoring and refusal tasks. The results, released by LatchBio, point to stronger safeguards built into the latest version of the model.
What the benchmarks measure
LatchBio's biosecurity benchmarks put AI models through a battery of tests designed to gauge how well they handle biological risks. Two areas get the most attention: biosecurity monitoring and refusal tasks.
Monitoring tests check whether a model can spot dangerous biological content or flag risky requests. Refusal tasks measure something simpler but just as critical — whether the model says no when it should. A model that catches a threat but then helps anyway fails the test.
Grok 4.6 excelled in both categories, according to the benchmark results. That combination matters because a safeguard is only as good as its follow-through.
How Grok 4.6 stacked up
On LatchBio's benchmarks, Grok 4.6 outperformed its peers across the board. The model led the field in biosecurity monitoring and refusal tasks, with the results showing a clear gap between Grok 4.6 and the other models tested.
The benchmark scores don't just rank the models — they show where the biggest differences are. Grok 4.6's lead was most pronounced in the refusal tasks, where it consistently declined requests that other models were more likely to entertain.
What the results say about safeguards
The findings indicate improved safeguards in Grok 4.6 compared with earlier versions and competing systems. Biosecurity has become a central concern for AI developers, and refusal behavior is one of the hardest things to get right. A model that's too permissive is dangerous; one that's too restrictive becomes useless.
LatchBio's benchmarks are designed to stress-test that balance. Grok 4.6's performance suggests the model has found a workable middle ground — it monitors effectively and refuses when it needs to, without the benchmarks flagging obvious failures.
The results position Grok 4.6 ahead of its peers on biosecurity, at least as measured by LatchBio's testing. Whether that lead holds in real-world use, where the scenarios are messier than any benchmark, is the open question. For now, the numbers put Grok 4.6 at the front of the pack.
